Is a complete EXOZ research report available?

No complete published report is available for eXoZymes, Inc. (EXOZ) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

eXoZymes, Inc. (EXOZ)

NASDAQ: EXOZ · USD

$4.71

+0.01 (+0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EXOZ analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	39.9M
Net income (ttm)	-9.7M
EPS (ttm)	-$1.15
Shares out	8.5M
Volume	5,831.552

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -9.7M
EPS (ttm): -$1.15
Market cap: 39.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EXOZ indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

USD

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002010788
Company name	eXoZymes, Inc.
Country	United States
Country code	US
Cusip	461874109
Employees	32
Employees Change	1%
Employees Change Percent	3.23
Enterprise value	$39.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4618741098
Last refreshed	2026-07-25
Market cap	$39.9M
Market cap category	Nano-Cap
Price	$4.71
Price currency	USD
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2836
Symbol	EXOZ
Website	https://www.exozymes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.22%
FCF yield	-17.75%
P/B ratio	26.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-9.7M
Net Income Growth Years	0%
Profit Per Employee	$-302,268
ROA	-81.64
ROCE	-416.7
ROE	-185.8
ROIC	-98.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.44%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4M
Cash	$1.4M
Current Assets	$2.1M
Current Liabilities	$1.6M
Debt	$1.2M
Debt Equity	$0.76
Equity	$1.5M
Liabilities	$2.5M
Long Term Assets	$1.9M
Long Term Liabilities	$908,356
Net Cash	$279,680
Net Cash By Market Cap	$0.7
Net Cash Growth	-96.11%
Net Debt Equity	$-0.18
Tangible Book Value	$1.5M
Tangible Book Value Per Share	$0.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Net Working Capital	$-602,078
Quick ratio	1.1
Working Capital	$507,585

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.42%
200-day SMA	10.49
50-day SMA	7.98
50-day SMA vs 200-day SMA	50under200
All Time High	23.99
All Time High Change	-80.37%
All Time High Date	2025-02-13
All Time Low	4.66
All Time Low Change	1.07%
All Time Low Date	2026-07-24
ATR	0.73
Beta1y	1.24
Beta2y	1.32
Ch YTD	-56.79
High	4.99
High52	18.4
High52 Date	2025-11-10
High52ch	-74.4%
Low	4.66
Low52	4.66
Low52 Date	2026-07-24
Low52ch	1.07%
Ma50ch	-40.95%
Price vs 200-day SMA	-55.11%
RSI	26.06
RSI Monthly	37.33
RSI Weekly	32.07
Sharpe ratio	-0.66x
Sortino ratio	-0.92
Total Return	-18.49%
Tr YTD	-56.79
Tr1m	-38.83%
Tr1w	-21.76%
Tr3m	-54.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-10.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,319,885%
Float Percent	74.54%
Net Borrowing	2,809
Shares Insiders	25.46%
Shares Institutions	47.43%
Shares Out	8,478,992
Shares Qo Q	0.78%
Shares Yo Y	18.49%
Short Float	0.25%
Short Ratio	1.71
Short Shares	0.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.3M
Average Volume	15,277.75x
Bv Per Share	0.18
CAPEX	$-196,475
Ch1m	-38.83
Ch1w	-21.76
Ch1y	-50.42
Ch3m	-54.32
Ch6m	-60.26
Change	0.21%
Change From Open	-5.61
Close	4.7
Days Gap	6.17
Depreciation Amortization	291,605
Dollar Volume	27,466.6
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-10.2M
EBITDA	$-9.9M
EPS	$-1.15
F Score	1
FCF	$-7.1M
FCF EV Yield	-17.88x
FCF Per Share	$-0.84
Financing CF	2,809
Fiscal Year End	December
Founded	2,014
Income Tax	$-105,205
Investing CF	-176,776
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	9.24
Ma150ch	-49.04%
Ma20	6.82
Ma20ch	-30.94%
Net CF	-7,066,915
Next Earnings Date	2026-08-11
Open	4.99
Optionable	No
Position In Range	15.15
Ppne	1,823,666
Price Date	2026-07-24
Ptbv Ratio	26.13
Relative Volume	0.38x
Share Based Comp	2,171,926
Tr6m	-60.26%
Us State	California
Volume	5,831.6

eXoZymes, Inc. (EXOZ)

Coverage state: Market snapshot only — no published research

Generate the first EXOZ analysis

Price

Financial snapshot

Fair-value bridge

Latest news · EXOZ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EXOZ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EXOZ

Frequently asked questions